Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine dipeptide-supplemented parenteral nutrition in critically ill patients
2004-001805-90Phase 4Completed
- Sponsor
- Fresenius Kabi
- Start
- Dec 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of alanyl glutamine in Critical illness with parenteral nutrition requirement and Healthcare-associated infection (HAI) (2 arms), sponsored by Fresenius Kabi. Primary endpoint: Incidence of nosocomial infection during ICU stay. Started Dec 2005; status: completed.
02
Drugs
alanyl glutamine
03
Conditions
Critical illness with parenteral nutrition requirementHealthcare-associated infection (HAI)
Beyond the preview
Go deeper on 2004-001805-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001805-90.